Oare; David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Oare; David.The latest application filed is for "muscarinic receptor antagonists".
- Oare; David - Belmont CA
| Patent | Date |
|---|---|
| Substituted 4-amino-benzylpiperidine compounds Grant 8,080,565 - Mammen , et al. December 20, 2 | 2011-12-20 |
| Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds Grant 8,030,502 - Mammen , et al. October 4, 2 | 2011-10-04 |
| Muscarinic receptor antagonists App 20090306134 - Aggen; James ; et al. | 2009-12-10 |
| Substituted 4-amino-benzylpiperidine compounds App 20090023777 - Mammen; Mathai ; et al. | 2009-01-22 |
| Muscarinic receptor antagonists Grant 7,456,203 - Aggen , et al. November 25, 2 | 2008-11-25 |
| Substituted 4-amino-1-benzylpiperidine compounds Grant 7,368,463 - Mammen , et al. May 6, 2 | 2008-05-06 |
| Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds App 20080091034 - Mammen; Mathai ; et al. | 2008-04-17 |
| Therapeutic carbamates Grant 7,238,709 - Mammen , et al. July 3, 2 | 2007-07-03 |
| Antagonists for treatment of CD/11CD18 adhesion receptor mediated disorders App 20050203135 - Burdick, Daniel J. ; et al. | 2005-09-15 |
| LFA-1 antagonist compounds App 20050148588 - Burdick, Daniel J. ; et al. | 2005-07-07 |
| LFA-1 antagonist compounds Grant 6,872,735 - Burdick , et al. March 29, 2 | 2005-03-29 |
| Substituted 4-amino-1-benzylpiperidine compounds App 20050026954 - Mammen, Mathai ; et al. | 2005-02-03 |
| Therapeutic ureas App 20040116706 - Mammen, Mathai ; et al. | 2004-06-17 |
| Muscarinic receptor antagonists App 20040110229 - Aggen, James ; et al. | 2004-06-10 |
| LFA-1 antagonist compounds App 20040058968 - Burdick, Daniel J. ; et al. | 2004-03-25 |
| Therapeutic ureas App 20040054187 - Mammen, Mathai ; et al. | 2004-03-18 |
| Muscarinic receptor antagonists Grant 6,693,202 - Aggen , et al. February 17, 2 | 2004-02-17 |
| Therapeutic carbamates App 20040029919 - Mammen, Mathai ; et al. | 2004-02-12 |
| LFA-1 antagonist compounds Grant 6,667,318 - Burdick , et al. December 23, 2 | 2003-12-23 |
| Therapeutic ureas Grant 6,635,764 - Mammen , et al. October 21, 2 | 2003-10-21 |
| Receptor specific atrial natriuretic peptides Grant 6,525,022 - Lowe , et al. February 25, 2 | 2003-02-25 |
| LFA-1 Antagonist compounds App 20020119994 - Burdick, Daniel J. ; et al. | 2002-08-29 |
| Therapeutic ureas App 20020049195 - Mammen, Mathai ; et al. | 2002-04-25 |
| Receptor specific atrial natriuretic peptides Grant 5,846,932 - Lowe , et al. December 8, 1 | 1998-12-08 |
| Ras farnesyl transferase inhibitors Grant 5,843,941 - Marsters, Jr. , et al. December 1, 1 | 1998-12-01 |
| Receptor specific atrial natriuretic peptides Grant 5,665,704 - Lowe , et al. September 9, 1 | 1997-09-09 |
| Ras farnesyl transferase inhibitors Grant 5,532,359 - Marsters, Jr. , et al. July 2, 1 | 1996-07-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 